Across 7 quantified broiler trials ranging from 640 to 2,056,857 birds in Turkey, Germany, Sri Lanka, Brazil, the USA, and Australia, Activo improved FCR by 2 to 15 points or improved mortality-adjusted FCR while also increasing final weight or ADG. Examples include 69,520 Ross 308 broilers in Turkey with 2-point lower FCR and 1.5% higher ADG, 50,000 broilers in Sri Lanka with FCR improving from 1.97 to 1.82, and 2,056,857 broilers in Brazil with 2-point better corrected FCR and 3% higher ADG.

In 5 quantified pig fattening trials covering 320 to 30,573 pigs in Germany, Brazil, and the Czech Republic, Activo improved feed conversion by 6 to 30 points or by 5% on average, with associated gains in ADG and shorter finishing periods. The strongest individual field result was the Czech trial with 6,272 pigs, where Activo improved adjusted FCR from 2.81 to 2.51, increased ADG from 815 to 912 g, shortened fattening by 13 days, and reduced mortality from 5.4% to 2.9%.

In 4 piglet/weaner trials conducted in Australia, Germany, and China, involving 140 pigs per weekly entry over four entries, 1,564 piglets, 815 piglets, and 192 weaned pigs, Activo or Activo-based programs improved weight gain, FCR, survivability, and gut-health outcomes. Reported effects included 1 kg higher weight gain and 13-19 points better FCR in Australian weaners, 50% lower mortality in a German post-weaning study, 800 g higher nursery weight versus a competitor product, and 38% vs. 61% diarrhea incidence versus challenged control in the Chinese E. coli K88 model.

In 7 quantified layer, breeder, and grandparent-stock trials in Germany, the Philippines, China/unspecified wheat-diet study context, the Czech Republic, India, and the Netherlands, trial sizes ranged from 480 layers to 25,835 commercial layers and 16,800 grandparents. Improvements included 1.4 g higher egg weight and 2.5% higher egg mass in 25,835 German layers, 11-point better FCR for egg mass in 480 Philippine layers, 3.24-3.36% higher production and 150 g more egg mass per hen in 576 Hy-Line layers, and 5.5 more hatchable eggs per hen housed in the Indian breeder GHM program.

In 6 challenge or microbiological trials with 192 weaned pigs, 450 broilers, 480 broilers, 640 broilers, 1,155 broilers, and 1,400 broilers in China, India, Brazil, Australia, and the USA, Activo-based treatments reduced disease-associated parameters. Specific findings included lower diarrhea incidence after E. coli K88 challenge, 6-7 log reductions in total bacterial counts in crop/caecum, 0.34-0.35 log lower enterobacteria in breast meat, 66% fewer severe footpad lesions vs. antibiotics, and lower NE lesion scores under necrotic enteritis challenge.

In 1 feed-processing stability trial conducted in Germany at DIL with analysis by IGV, 10 samples per processing temperature were analyzed. Activo showed the highest recovery rate among tested products, with 94.7% recovery after pelleting at 70 °C for approx. 3 minutes and 82.1% recovery at 90 °C, supporting the technological stability of the microencapsulated phytomolecule formulation rather than an in-vivo performance claim.